Telehealth Collaborative Care Model (CoCM) in Lung Cancer

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Abramson Cancer Center at Penn Medicine
Study ID
NCT07102147
Status
Recruiting
Apply to this trial

Conditions

  • Anxiety
  • Depression in Adults
  • Lung Cancer (Diagnosis)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • High Touch Outreach — BEHAVIORAL
    Gain-framed message, informational flyer, and direct request

Study Details

The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.

Key Dates

Start date
Aug 18, 2025
Status verified
May 2026
Primary completion
Mar 31, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: High Touch Outreach
    Patients in the high touch outreach arm will receive a gain-framed message via text (preferred modality), MyPennMedicine message, email, and/or postal mail that links to the digital screener; an informational flyer about collaborative care sent via postal mail, the MyPennMedicine portal, email, and/or text; and a direct request from their oncology provider to collaborative care for those patients who have not responded to outreach efforts by their next oncology visit post-referral.
  • No Intervention: Standard Outreach
    Patients in the standard outreach arm will receive a standard message sent via text (preferred modality), MyPennMedicine message, email, and/or postal mail that links to the digital screener; this message is one that is similar to that already used in Penn Integrated Care's practice.

Primary Outcome Measure

Reach - Completion of the intake assessment amongst referred patients. [ Time Frame: Measured per patient up to 30 days after randomization. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Abramson Cancer Center at the University of PennsylvaniaPhiladelphiaPennsylvania19104
Alexandria Muench, PsyD
[email protected]
215-421-4491
Courtney Wolk, PhD (SUB_INVESTIGATOR)
Matthew Press, MD, MSc (SUB_INVESTIGATOR)
Aditi Singh, MD (SUB_INVESTIGATOR)
Faith Mutale, CRNP (SUB_INVESTIGATOR)
Katharine Rendle, PhD, MSW (SUB_INVESTIGATOR)
Anil Vachani, MD, MS (SUB_INVESTIGATOR)
Kristin Linn, PhD (SUB_INVESTIGATOR)
Eleanor Anderson, MD (SUB_INVESTIGATOR)
Tiffany Hogan, MA, CCC-SLP (SUB_INVESTIGATOR)

Find similar trials in Philadelphia, PA

By research site
Abramson Cancer Center at the University of Pennsylvania· Philadelphia, PA

Related Studies